Patient-reported Outcomes
Patient-reported outcomes (PROs) provide essential safety and tolerability data to inform clinical care and regulatory decisions; however, their use in early phase settings and integration with clinical and wearable data to target interventions is limited. Furthermore, trials using PROs often fail to address cultural or health specificities of under-served populations. This theme will address “unacceptable health inequalities” by facilitating participation in patient-centred research from under-served populations. PROs are particularly important in chronic/inflammatory disease, as improvements in clinical outcomes may be challenging to measure, and curative therapies not yet widely available. The target of intervention in these conditions may be to reduce symptom burden and improve quality of life.
Theme Leads
Professor Mel Calvert
Associate Professor Lee Aiyegbusi
Related news
BRC researchers receive prestigious NIHR award
Professors Melanie Calvert and Richard Riley have been recognised with a National Institute for Health and
New recommendations make it easier for patients to feed back on their health
Patients providing feedback on their health during research or in clinical practice could now find it
Toolkit helps researchers develop more equitable and representative research
Groups of people currently under-represented in clinical trials could benefit from improved health prospects – thanks
